Report Detail

Other 2018-2023 Global Point-of-care Infectious Disease Diagnostics Market Report (Status and Outlook)

  • RnM2475904
  • |
  • 12 October, 2018
  • |
  • Global
  • |
  • 115 pages
  • |
  • LPI(LP Information)
  • |
  • Other

2018-2023 Global Point-of-care Infectious Disease Diagnostics Market Report (Status and Outlook)

Table of Contents

    2018-2023 Global Point-of-care Infectious Disease Diagnostics Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Point-of-care Infectious Disease Diagnostics Market Size 2013-2023
        • 2.1.2 Point-of-care Infectious Disease Diagnostics Market Size CAGR by Region
      • 2.2 Point-of-care Infectious Disease Diagnostics Segment by Type
        • 2.2.1 HIV POC
        • 2.2.2 Clostridium Difficile POC
        • 2.2.3 HBV POC
        • 2.2.4 Respiratory Syncytial Virus POC
        • 2.2.5 HPV POC
        • 2.2.6 Influenza/Flu POC
        • 2.2.7 HCV POC
        • 2.2.8 MRSA POC
        • 2.2.9 TB and Drug-Resistant TB POC
      • 2.3 Point-of-care Infectious Disease Diagnostics Market Size by Type
        • 2.3.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Type (2013-2018)
        • 2.3.2 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Type (2013-2018)
      • 2.4 Point-of-care Infectious Disease Diagnostics Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Clinics
        • 2.4.3 Home
        • 2.4.4 Assisted Living Healthcare Facilities
        • 2.4.5 Laboratories
        • 2.4.6 Others
      • 2.5 Point-of-care Infectious Disease Diagnostics Market Size by Application
        • 2.5.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Application (2013-2018)
        • 2.5.2 Global Point-of-care Infectious Disease Diagnostics Market Size Growth Rate by Application (2013-2018)

      3 Global Point-of-care Infectious Disease Diagnostics by Players

      • 3.1 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Players
        • 3.1.1 Global Point-of-care Infectious Disease Diagnostics Market Size by Players (2016-2018)
        • 3.1.2 Global Point-of-care Infectious Disease Diagnostics Market Size Market Share by Players (2016-2018)
      • 3.2 Global Point-of-care Infectious Disease Diagnostics Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Point-of-care Infectious Disease Diagnostics by Regions

      • 4.1 Point-of-care Infectious Disease Diagnostics Market Size by Regions
      • 4.2 Americas Point-of-care Infectious Disease Diagnostics Market Size Growth
      • 4.3 APAC Point-of-care Infectious Disease Diagnostics Market Size Growth
      • 4.4 Europe Point-of-care Infectious Disease Diagnostics Market Size Growth
      • 4.5 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size Growth

      5 Americas

      • 5.1 Americas Point-of-care Infectious Disease Diagnostics Market Size by Countries
      • 5.2 Americas Point-of-care Infectious Disease Diagnostics Market Size by Type
      • 5.3 Americas Point-of-care Infectious Disease Diagnostics Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Point-of-care Infectious Disease Diagnostics Market Size by Countries
      • 6.2 APAC Point-of-care Infectious Disease Diagnostics Market Size by Type
      • 6.3 APAC Point-of-care Infectious Disease Diagnostics Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Point-of-care Infectious Disease Diagnostics by Countries
      • 7.2 Europe Point-of-care Infectious Disease Diagnostics Market Size by Type
      • 7.3 Europe Point-of-care Infectious Disease Diagnostics Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Point-of-care Infectious Disease Diagnostics by Countries
      • 8.2 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Type
      • 8.3 Middle East & Africa Point-of-care Infectious Disease Diagnostics Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Point-of-care Infectious Disease Diagnostics Market Forecast

      • 10.1 Global Point-of-care Infectious Disease Diagnostics Market Size Forecast (2018-2023)
      • 10.2 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions
        • 10.2.1 Global Point-of-care Infectious Disease Diagnostics Forecast by Regions (2018-2023)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Point-of-care Infectious Disease Diagnostics Forecast by Type
      • 10.8 Global Point-of-care Infectious Disease Diagnostics Forecast by Application

      11 Key Players Analysis

      • 11.1 Thermo Fisher Scientific
        • 11.1.1 Company Details
        • 11.1.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.1.3 Thermo Fisher Scientific Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.1.4 Main Business Overview
        • 11.1.5 Thermo Fisher Scientific News
      • 11.2 Alere
        • 11.2.1 Company Details
        • 11.2.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.2.3 Alere Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.2.4 Main Business Overview
        • 11.2.5 Alere News
      • 11.3 Calypte Biomedical
        • 11.3.1 Company Details
        • 11.3.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.3.3 Calypte Biomedical Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.3.4 Main Business Overview
        • 11.3.5 Calypte Biomedical News
      • 11.4 Chembio Diagnostic Systems
        • 11.4.1 Company Details
        • 11.4.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.4.3 Chembio Diagnostic Systems Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.4.4 Main Business Overview
        • 11.4.5 Chembio Diagnostic Systems News
      • 11.5 Meridian Bioscience
        • 11.5.1 Company Details
        • 11.5.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.5.3 Meridian Bioscience Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.5.4 Main Business Overview
        • 11.5.5 Meridian Bioscience News
      • 11.6 MedMira
        • 11.6.1 Company Details
        • 11.6.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.6.3 MedMira Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.6.4 Main Business Overview
        • 11.6.5 MedMira News
      • 11.7 Trinity Biotech
        • 11.7.1 Company Details
        • 11.7.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.7.3 Trinity Biotech Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.7.4 Main Business Overview
        • 11.7.5 Trinity Biotech News
      • 11.8 Sekisui Diagnostics
        • 11.8.1 Company Details
        • 11.8.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.8.3 Sekisui Diagnostics Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.8.4 Main Business Overview
        • 11.8.5 Sekisui Diagnostics News
      • 11.9 OraSure Technologies
        • 11.9.1 Company Details
        • 11.9.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.9.3 OraSure Technologies Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.9.4 Main Business Overview
        • 11.9.5 OraSure Technologies News
      • 11.10 Quidel
        • 11.10.1 Company Details
        • 11.10.2 Point-of-care Infectious Disease Diagnostics Product Offered
        • 11.10.3 Quidel Point-of-care Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2016-2018)
        • 11.10.4 Main Business Overview
        • 11.10.5 Quidel News

      12 Research Findings and Conclusion

      In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Point-of-care Infectious Disease Diagnostics market for 2018-2023.

      Point of care diagnosis allows for early detection of diseases and can greatly impact the medical outcome of the disease treatment.
      The point-of-care infectious disease diagnostics market is expected to register a fast growth over the forecast period owing to the emerging trend of patient-centric services and escalating incidence rates of complicated infectious disorders.
      Over the next five years, LPI(LP Information) projects that Point-of-care Infectious Disease Diagnostics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

      This report presents a comprehensive overview, market shares and growth opportunities of Point-of-care Infectious Disease Diagnostics market by product type, application, key companies and key regions.

      To calculate the market size, LP Information considers value generated from the sales of the following segments:

      Segmentation by product type:
      HIV POC
      Clostridium Difficile POC
      Respiratory Syncytial Virus POC
      HPV POC
      Influenza/Flu POC
      HCV POC
      MRSA POC
      TB and Drug-Resistant TB POC
      Segmentation by application:
      Hospitals
      Clinics
      Home
      Assisted Living Healthcare Facilities
      Laboratories
      Others

      We can also provide the customized separate regional or country-level reports, for the following regions:
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
      Thermo Fisher Scientific
      Alere
      Calypte Biomedical
      Chembio Diagnostic Systems
      Meridian Bioscience
      MedMira
      Trinity Biotech
      Sekisui Diagnostics
      OraSure Technologies
      Quidel

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Point-of-care Infectious Disease Diagnostics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
      To understand the structure of Point-of-care Infectious Disease Diagnostics market by identifying its various subsegments.
      Focuses on the key global Point-of-care Infectious Disease Diagnostics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Point-of-care Infectious Disease Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Point-of-care Infectious Disease Diagnostics submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.


      Summary:
      Get latest Market Research Reports on Point-of-care Infectious Disease Diagnostics. Industry analysis & Market Report on Point-of-care Infectious Disease Diagnostics is a syndicated market report, published as 2018-2023 Global Point-of-care Infectious Disease Diagnostics Market Report (Status and Outlook). It is complete Research Study and Industry Analysis of Point-of-care Infectious Disease Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,660.00
      $6,990.00
      $9,320.00
      3,703.94
      5,555.91
      7,407.88
      4,152.27
      6,228.40
      8,304.53
      505,903.58
      758,855.37
      1,011,807.16
      325,582.55
      488,373.83
      651,165.10
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report